================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 1, 2008
BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-10783 75-1590407
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (801) 972-5555
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
1
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 1, 2008, the Board of Directors of BSD Medical Corporation
("BSD") elected Timothy C. McQuay as a director of BSD. Mr. McQuay will receive
the standard compensation that each non-employee director of BSD receives,
including participating in the 1998 Director Stock Plan, which compensation is
described in BSD's proxy statement relating to its 2008 annual meeting. Board
committee assignments for Mr. McQuay will be determined at a later date. There
is no arrangement or understanding pursuant to which Mr. McQuay was selected as
a director, and there are no related party transactions between BSD and Mr.
McQuay that are reportable under Item 404(a) of Regulation S-K. A copy of the
press release announcing Mr. McQuay's election is attached as Exhibit 99.1 to
this current report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release of BSD Medical Corporation dated February 4, 2008.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 4, 2008
BSD MEDICAL CORPORATION
By: /s/ Hyrum A. Mead
-------------------------------
Name: Hyrum A. Mead
Title: President and Chief Executive
Officer
3
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release of BSD Medical Corporation dated February 4, 2008
4
--------------------------------------------------------------------------------